Allstate Corporation’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-37,758
Closed -$479K 781
2021
Q4
$479K Sell
37,758
-6,862
-15% -$89.3K 0.01% 678
2021
Q3
$559K Hold
44,620
0.02% 488
2021
Q2
$672K Sell
44,620
-8,320
-16% -$125K 0.02% 439
2021
Q1
$728K Buy
52,940
+20,297
+62% +$315K 0.02% 410
2020
Q4
$592K Buy
32,643
+6,541
+25% +$101K 0.02% 441
2020
Q3
$331K Buy
+26,102
New +$327K 0.01% 544

Other funds holding PTVE

Allstate Corporation's PTVE Position: Q1 2022 in Review

Allstate Corporation sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q1 2022, closing a stake of 37,758 shares — an estimated $479K sold.

Allstate Corporation first reported a position in PTVE in Q3 2020 and held it in 6 quarters. The position peaked at $728K in Q1 2021. 103 funds tracked by Wall St. Rank hold PTVE as of Q1 2022.

  • Allstate Corporation reported no remaining Pactiv Evergreen Inc. Common stock position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 37,758 Pactiv Evergreen Inc. Common stock shares in Q1 2022, an estimated $479K.
  • Allstate Corporation first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 6 quarters.
  • Allstate Corporation's Pactiv Evergreen Inc. Common stock position peaked at $728K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.